DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,978 filers reported holding DANAHER CORPORATION in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $913 | -11.5% | 3,686 | -14.4% | 0.02% | -5.0% |
| Q2 2023 | $1,032 | +10220.0% | 4,305 | +10662.5% | 0.02% | – |
| Q1 2023 | $10 | 0.0% | 40 | 0.0% | 0.00% | – |
| Q4 2022 | $10 | -100.0% | 40 | -60.0% | 0.00% | -100.0% |
| Q1 2022 | $29,000 | -87.9% | 100 | -86.3% | 0.00% | -80.0% |
| Q4 2021 | $239,000 | +431.1% | 728 | +385.3% | 0.01% | +400.0% |
| Q3 2021 | $45,000 | +12.5% | 150 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $40,000 | -52.9% | 150 | -62.1% | 0.00% | -66.7% |
| Q3 2020 | $85,000 | 0.0% | 396 | -17.7% | 0.00% | -25.0% |
| Q2 2020 | $85,000 | -75.3% | 481 | -77.5% | 0.00% | -82.6% |
| Q1 2020 | $344,000 | -71.7% | 2,135 | -76.7% | 0.02% | -76.3% |
| Q1 2019 | $1,214,000 | -8.7% | 9,169 | -29.0% | 0.10% | -24.8% |
| Q4 2018 | $1,330,000 | -39.2% | 12,906 | -35.9% | 0.13% | -3.7% |
| Q3 2018 | $2,187,000 | +401.6% | 20,135 | +355.1% | 0.13% | +378.6% |
| Q2 2018 | $436,000 | +30.5% | 4,424 | +29.4% | 0.03% | -12.5% |
| Q1 2018 | $334,000 | +14.4% | 3,420 | +8.6% | 0.03% | -15.8% |
| Q4 2017 | $292,000 | +27.5% | 3,150 | +18.6% | 0.04% | -30.9% |
| Q3 2017 | $229,000 | +16.2% | 2,655 | +13.5% | 0.06% | -32.1% |
| Q2 2017 | $197,000 | -85.1% | 2,340 | -84.9% | 0.08% | -40.9% |
| Q1 2017 | $1,321,000 | +23.3% | 15,454 | +12.1% | 0.14% | +12.3% |
| Q4 2016 | $1,071,000 | +25.6% | 13,784 | +26.4% | 0.12% | +17.3% |
| Q3 2016 | $853,000 | +903.5% | 10,909 | +1198.7% | 0.10% | +766.7% |
| Q2 2016 | $85,000 | +66.7% | 840 | +53.0% | 0.01% | +140.0% |
| Q1 2016 | $51,000 | +37.8% | 549 | +40.1% | 0.01% | +25.0% |
| Q4 2015 | $37,000 | – | 392 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |